FR3132023B1 - Ingredient protecteur de la peau et/ou des muqueuses contre les facteurs de virulence - Google Patents

Ingredient protecteur de la peau et/ou des muqueuses contre les facteurs de virulence Download PDF

Info

Publication number
FR3132023B1
FR3132023B1 FR2200627A FR2200627A FR3132023B1 FR 3132023 B1 FR3132023 B1 FR 3132023B1 FR 2200627 A FR2200627 A FR 2200627A FR 2200627 A FR2200627 A FR 2200627A FR 3132023 B1 FR3132023 B1 FR 3132023B1
Authority
FR
France
Prior art keywords
derivatives
salts
skin
virulence factors
protective ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2200627A
Other languages
English (en)
French (fr)
Other versions
FR3132023A1 (fr
Inventor
Valérie Andre
Isabelle Bonnet
Manon Gault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Beauty Care Solutions France SAS
Original Assignee
BASF Beauty Care Solutions France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF Beauty Care Solutions France SAS filed Critical BASF Beauty Care Solutions France SAS
Priority to FR2200627A priority Critical patent/FR3132023B1/fr
Priority to CN202380018479.9A priority patent/CN118591367A/zh
Priority to PCT/FR2023/050094 priority patent/WO2023144487A1/fr
Priority to EP23706401.9A priority patent/EP4469019A1/de
Publication of FR3132023A1 publication Critical patent/FR3132023A1/fr
Application granted granted Critical
Publication of FR3132023B1 publication Critical patent/FR3132023B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/733—Alginic acid; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
FR2200627A 2022-01-25 2022-01-25 Ingredient protecteur de la peau et/ou des muqueuses contre les facteurs de virulence Active FR3132023B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR2200627A FR3132023B1 (fr) 2022-01-25 2022-01-25 Ingredient protecteur de la peau et/ou des muqueuses contre les facteurs de virulence
CN202380018479.9A CN118591367A (zh) 2022-01-25 2023-01-24 用于保护皮肤和/或黏膜免受毒力因子影响的成分
PCT/FR2023/050094 WO2023144487A1 (fr) 2022-01-25 2023-01-24 Ingredient protecteur de la peau et/ou des muqueuses contre les facteurs de virulence
EP23706401.9A EP4469019A1 (de) 2022-01-25 2023-01-24 Inhaltsstoff zum schutz der haut und/oder schleimhäute vor virulenzfaktoren

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2200627A FR3132023B1 (fr) 2022-01-25 2022-01-25 Ingredient protecteur de la peau et/ou des muqueuses contre les facteurs de virulence
FR2200627 2022-01-25

Publications (2)

Publication Number Publication Date
FR3132023A1 FR3132023A1 (fr) 2023-07-28
FR3132023B1 true FR3132023B1 (fr) 2024-01-05

Family

ID=81325006

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2200627A Active FR3132023B1 (fr) 2022-01-25 2022-01-25 Ingredient protecteur de la peau et/ou des muqueuses contre les facteurs de virulence

Country Status (4)

Country Link
EP (1) EP4469019A1 (de)
CN (1) CN118591367A (de)
FR (1) FR3132023B1 (de)
WO (1) WO2023144487A1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2654255A1 (en) 2006-06-28 2008-01-03 Novozymes Biopolymer A/S Compositions with several hyaluronic acid fractions for cosmetic and medical uses
FR2994387B1 (fr) 2012-08-13 2016-07-29 Basf Beauty Care Solutions France Sas Ingredient hydratant cosmetique ou pharmaceutique
FR3064473B1 (fr) 2017-04-03 2021-02-12 Basf Beauty Care Solutions France Sas Ingredient protecteur de l'equilibre de la flore microbienne cutanee et/ou mucosale
US10675234B1 (en) * 2019-02-22 2020-06-09 N.V. Perricone Llc Systems and methods for treating and/or preventing acne

Also Published As

Publication number Publication date
EP4469019A1 (de) 2024-12-04
FR3132023A1 (fr) 2023-07-28
WO2023144487A1 (fr) 2023-08-03
CN118591367A (zh) 2024-09-03

Similar Documents

Publication Publication Date Title
MX2023012795A (es) Compuesto de triazina sustituida.
MX2023007192A (es) Inhibidores de prmt5.
SA523440916B1 (ar) Prmt5 مشتقات كربوكساميد ثلاثية الحلقة كمثبطات
MX2024011056A (es) Compuesto heterociclico para inducir la degradacion de la proteina kras mutante g12d.
MA56883B1 (fr) Dérivés de 2-hydroxycycloalcane-1-carbamoyle
ZA202403388B (en) Small molecules for treatement of cancer
MA55046B1 (fr) Utilisation de dérivés d'indole n-substitués comme modulateurs des récepteurs des pge2
MA56748B1 (fr) Formes à l'état solide de (s)-2-(((s)-6,8-difluoro-1,2,3,4-tétrahydronaphthalén-2-yl)amino)-n-(1-(2-méthyl-1-(néopentylamino)propan-2-yl)-1h-imidazol-4-yl)pentanamide et utilisations assosiées
MX2023003627A (es) Derivados de 1,2,3,4-tetrahidroquinolina como inhibidores de la activacion de yap/taz-tead para el tratamiento del cancer.
AU2020281332A8 (en) Dna-dependent protein kinase inhibitor
CY1115001T1 (el) Νεα παραγωγα φαινυλιμιδαζολιου ως αναστολεις ενζυμου pde10a
MA63589B1 (fr) Dérivés d'alpha-d-galactopyranoside substitués par triazolyl-méthyle
WO2021168483A3 (en) Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitors
MA35411B1 (fr) Nouvelle composition thérapeutique contenant de l'apomorphine comme principe actif
WO2023073013A8 (en) Lrrk2 inhibitors
WO2023196720A3 (en) Lrrk2 inhibitors
WO2022192594A3 (en) Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease
WO2022268935A3 (en) Process for the preparation of nlrp3 inhibitors
MX2025011346A (es) Compuestos de quinolinona amida y usos de los mismos
FR3132023B1 (fr) Ingredient protecteur de la peau et/ou des muqueuses contre les facteurs de virulence
MX2023012204A (es) Derivados de piperidina urea como inhibidores de la epóxido hidrolasa soluble.
MX2023007476A (es) Derivado de tetrahidroquinolina y uso medico del mismo.
GEAP202516749A (en) Methods of treating cancers using isoquinoline or 6-aza-quinoline derivatives
MX2025003004A (es) Formas farmaceuticas de un inhibidor de cd73
MX2025002407A (es) Inhibidores de egfr y sus usos

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20230728

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5